Dr. Natale on the Utility of PD-L1 and TMB in Lung Cancer
March 3rd 2020Ronald B. Natale, MD, medical director, Clinical Lung Cancer Program and assistant clinical professor of medicine, Cedars-Sinai, discusses the utility of PD-L1 expression and tumor mutational burden (TMB) in lung cancer.
Read More